Navigation Links
BioCryst Pharmaceuticals to Announce First Quarter 2008 Financial Results on May 8, 2008
Date:5/1/2008

BIRMINGHAM, Ala., May 1 /PRNewswire-FirstCall/ -- BioCryst Pharmaceuticals (Nasdaq: BCRX) today announced that its first quarter 2008 financial results will be released on Thursday, May 8, 2008. At 8:30 a.m. Eastern Time BioCryst will host a conference call and webcast to discuss the financial results and provide an update on the Company's programs and further clinical data. The call will be led by Jon P. Stonehouse, BioCryst's Chief Executive Officer, and Stuart Grant, BioCryst's Chief Financial Officer.

The webcast can be accessed by logging onto http://www.biocryst.com. Please connect to the website at least 15 minutes prior to the conference call to ensure adequate time for any software download that may be needed to hear the webcast. To participate in the conference call, please dial 1-800-860- 2442 (U.S.). The audio portion of the webcast will be archived and available for replay for 14 days.

About BioCryst

BioCryst Pharmaceuticals, Inc. is a leader in the use of crystallography and structure-based drug design for the development of novel therapeutics to treat cancer, cardiovascular diseases, autoimmune diseases, and viral infections. The Company is advancing multiple internal programs toward potential commercialization including forodesine HCl in oncology, BCX-4208 in transplantation and autoimmune diseases and peramivir in seasonal and life-threatening influenza. BioCryst has a worldwide partnership with Roche for the development and commercialization of BCX-4208, and is collaborating with Mundipharma for the development and commercialization of forodesine HCl in markets across Europe, Asia, Australia and certain neighboring countries. In January 2007, the U.
'/>"/>

SOURCE BioCryst Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. BioCryst to Release Third Quarter 2007 Financial Results on Thursday, November 8, 2007
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
4. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
5. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
6. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
7. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
8. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
9. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
10. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
11. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... Falls Church, VA (PRWEB) May 07, 2015 ... the Impact of NSF/IPEC/ANSI 363-2014, **FDAnews Webinar**, May ... EDT, http://www.fdanews.com/NewGMPStandards , Most drugs contain ... flow aids, binding agents or other purposes that ... The globalization of the pharma industry, combined with ...
(Date:5/6/2015)... With recent headlines about the kidnapping of Bossini clothing ... from Southern China, it is becoming apparent to people all ... them. This is especially true for High Net Worth Individuals ... through the property they own, the schools their children attend ... individuals, families and companies that are at higher risk than ...
(Date:5/6/2015)... Jersey (PRWEB) May 06, 2015 With ... asthma and subject to its potentially dangerous health effects, ... state-wide program – BEAM (Breathe Easier with Asthma Management) ... The program is being funded through a $500,000 foundation ... Jersey (BGCNJ), which is implementing BEAM throughout the state. ...
(Date:5/6/2015)... As the exclusive hospital of the Tampa Bay Buccaneers, Florida ... Raymond James Stadium for all the “Bucs Babies” celebrating their ... into the “Bucs Babies” program last year. , “It ... particularly those born at the Florida Hospitals here in our ... really enjoyed my time participating in the festivities, interacting with ...
(Date:5/6/2015)... Beach, VA (PRWEB) May 06, 2015 ... and services, today announced it won the Software ... CODiE Award in the "Best Postsecondary Learning Management ... in 2011 and has been finalists for this award ... and innovation that stands out in the industry. ...
Breaking Medicine News(10 mins):Health News:FDAnews Announces — New Standards for Excipient GMPs: Analyzing the Impact of NSF/IPEC/ANSI 363-2014 Webinar, May 27, 2015 2Health News:FDAnews Announces — New Standards for Excipient GMPs: Analyzing the Impact of NSF/IPEC/ANSI 363-2014 Webinar, May 27, 2015 3Health News:Pacific Prime China Now Offering Kidnapping & Ransom Insurance 2Health News:The Horizon Foundation for New Jersey and Boys & Girls Clubs in New Jersey Join Forces to Help Children with Asthma 2Health News:The Horizon Foundation for New Jersey and Boys & Girls Clubs in New Jersey Join Forces to Help Children with Asthma 3Health News:The Horizon Foundation for New Jersey and Boys & Girls Clubs in New Jersey Join Forces to Help Children with Asthma 4Health News:Florida Hospital and the Tampa Bay Buccaneers Celebrate “Bucs Babies” Who are Turning One this Month with a Party on the Pirate Ship 2Health News:Florida Hospital and the Tampa Bay Buccaneers Celebrate “Bucs Babies” Who are Turning One this Month with a Party on the Pirate Ship 3Health News:Edvance360 Wins 2015 CODiE Award for Best LMS, Winning Twice and Maintaining Finalist Status for Seven Years Running 2Health News:Edvance360 Wins 2015 CODiE Award for Best LMS, Winning Twice and Maintaining Finalist Status for Seven Years Running 3
... Neurobiological,Technologies, Inc. ("NTI") (Nasdaq: NTII ) today ... by The NASDAQ Stock Market that it has,regained ... Previously, the NASDAQ Listing Qualifications Department had,notified NTI ... $35 million market,value of listed securities continued listing ...
... for Baby Boomers In ... Search of Better Sex, ... during the,holidays that recipients will love. But one product is, in ... ), To view the Multimedia News Release, go to: ...
... November 20 Stora Enso, a leading producer,of ... the first,intelligent pharmaceutical packaging solution to use Cypak,s ... electronic module built,around a single RFID microchip and ... sensors are printed onto the packaging,to detect when ...
... WHO Cuts Global AIDS Estimate by Six Million; AHF Questions Numbers, Seeks ... ... As the World Health,Organization (WHO) prepares to announce a dramatic decrease in ... to 33,million in a report to be released Wednesday, AIDS Healthcare Foundation,(AHF) ...
... MYL ),announced that it completed the sale of 2.14 ... per share and 53.5 million,shares of common stock at ... filed with the Securities and Exchange Commission. The,amounts sold ... underwriters, exercise of the overallotment option. The offerings ...
... Viant, Inc., a leader in,healthcare payment and cost ... as Executive Vice President of Network,Development. Mr. Vangeison ... on delivering quality and value to many of ... Vangeison will have responsibility for all network strategy,including ...
Cached Medicine News:Health News:Give the Gift of Love With Women's Intimacy Product that Increases Pleasure for Both Partners 2Health News:Give the Gift of Love With Women's Intimacy Product that Increases Pleasure for Both Partners 3Health News:Cypak Compliancy Connection Powers Stora Enso Pharma DDSi 2Health News:WHO's New Global AIDS Numbers: 'Let's Stop Guessing,' Says AHF 2Health News:Mylan Completes $2.89 Billion of Equity Financings, Including Exercise of Overallotment Option of Mandatory Convertible Preferred Stock 2Health News:Mylan Completes $2.89 Billion of Equity Financings, Including Exercise of Overallotment Option of Mandatory Convertible Preferred Stock 3Health News:Viant Appoints Keith Vangeison as Executive Vice President of Network Development 2
(Date:5/6/2015)... (NYSE: CVS ) officially announced today that it will rebuild ... fire damage during protests last week.  "As we watched ... past week or so, our hearts turned from pain to the ... Larry Merlo . "Our purpose as a company is helping ... way that we can fulfill that purpose than to reopen our ...
(Date:5/6/2015)... 6, 2015 Fibich, Leebron, Copeland, Briggs & ... settlement has been reached to resolve lawsuits involving individuals ... Actos. Actos - manufactured by Takeda Pharmaceuticals - has ... cancer. Several of the firm,s attorneys were instrumental in ... Tommy Fibich - Founding Partner of Fibich, ...
(Date:5/6/2015)... Research and Markets ( http://www.researchandmarkets.com/research/jskhnb/energy_based ) has ... - Global Strategic Business Report" report to their offering. ... US, Canada , Japan ... , and Rest of World. Annual estimates and forecasts are ... historic analysis is provided for these markets. The ...
Breaking Medicine Technology:CVS Health Announces it Will Rebuild Baltimore CVS/pharmacy Locations 2Takeda Agrees to $2.4 Billion Settlement for Actos Bladder Cancer Lawsuits 2Energy based Ablation Devices - Global Strategic Business Report 2015: Increasing Incidence of Cancer Bodes Well For Energy Based Ablation Devices 2Energy based Ablation Devices - Global Strategic Business Report 2015: Increasing Incidence of Cancer Bodes Well For Energy Based Ablation Devices 3
... 15, 2011 Nephros, Inc. (OTC Bulletin Board: ... marketing filtration products for therapeutic applications, infection control, and ... Inc. effected a one-for-twenty reverse stock split at 5:00 ... by the Financial Industry Regulatory Authority (FINRA) that FINRA ...
... and BALTIMORE, March 15, 2011 ... innovate, implement and commercialize next generation of medical image ... leading clinicians and advanced engineering technologists. ... international communications and information technology company, and Johns Hopkins ...
Cached Medicine Technology:Nephros Announces Split Adjusted Trade Date 2Nephros Announces Split Adjusted Trade Date 3Harris Corporation and Johns Hopkins Medicine Announce Joint Venture to Develop Innovative Medical Image Management Solutions 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: